Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

620
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
620
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

607
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
607
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

2.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.4K
Ethical Issues01:27

Ethical Issues

2.1K
Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
2.1K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the EBMT.

Leukemia·2021
Same author

CD4<sup>+</sup>CD8<sup>+</sup> T-Lymphocytes in Xenogeneic and Human Graft-versus-Host Disease.

Frontiers in immunology·2020
Same author

Comparison of mycophenolate mofetil and calcineurin inhibitor versus calcineurin inhibitor-based graft-versus-host-disease prophylaxis for matched unrelated donor transplant in acute myeloid leukemia. A study from the ALWP of the EBMT.

Bone marrow transplantation·2020
Same author

Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT).

Cancer medicine·2020
Same author

Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMT.

Bone marrow transplantation·2020
Same author

One-year efficacy and safety of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria naïve to complement inhibitor therapy: open-label extension of a randomized study.

Therapeutic advances in hematology·2020

Related Experiment Videos

Current issues in chronic graft-versus-host disease.

Gérard Socié1, Jerome Ritz2

  • 1Assistance Publique-Hopitaux de Paris, Hospital Saint Louis, Division of Hematology/Immunology/Oncology, Hematology Transplantation, Paris, France; University Paris VII, Denis Diderot, Paris, France; INSERM U1160, Team GVHD and Allogeneic Transplantation, Paris, France;

Blood
|June 11, 2014
PubMed
Summary

Chronic graft-versus-host disease (GVHD) is a serious complication after stem cell transplants, affecting more patients due to older recipients and unrelated donors. Advances in understanding GVHD pathophysiology and diagnosis are improving its prevention and treatment.

Related Experiment Videos

Area of Science:

  • Hematology
  • Immunology
  • Transplantation Medicine

Background:

  • Chronic graft-versus-host disease (GVHD) is a common and serious complication following allogeneic hematopoietic stem cell transplantation.
  • The incidence of chronic GVHD is increasing due to the transplantation of older patients and the greater use of unrelated donors.

Purpose of the Study:

  • To review recent advances in understanding the pathophysiology of chronic GVHD.
  • To discuss precise criteria for the diagnosis and classification of chronic GVHD manifestations.
  • To highlight how these advances may improve prophylaxis and treatment strategies for chronic GVHD.

Main Methods:

  • Literature review of recent research on chronic GVHD.
  • Analysis of diagnostic and classification criteria for chronic GVHD.
  • Synthesis of current understanding of GVHD pathophysiology.

Main Results:

  • Significant progress has been made in elucidating the underlying mechanisms of chronic GVHD.
  • Standardized criteria for diagnosing and classifying chronic GVHD are being established.
  • Improved understanding facilitates better management approaches.

Conclusions:

  • Recent scientific advances are enhancing the understanding of chronic GVHD.
  • Precise diagnostic and classification criteria are crucial for effective management.
  • These developments hold promise for improving the prophylaxis and treatment of chronic GVHD.